EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study – Study protocol

S Anderson, M C Douglas, R Valentine, L Grocutt, G J Inman, L Hay, S Wright, K Mair, C Kelly, R Seddon, A Shaw, MacMillan A und 11 weitere

Clinical and Translational Radiation Oncology · 2026-09 · 60 · 101245

DOI: 10.1016/j.ctro.2026.101245 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Clinical and Translational Radiation Oncology, 2026-09. Verfasst von S Anderson und 22 weiteren Autor:innen. Beteiligte Einrichtung: Beatson West of Scotland Cancer Centre, Glasgow. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beatson Cancer Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

biologically adaptivedose escalationhead and neck cancerradiotherapy

Autor:innen und Institutionen

  • Beatson West of Scotland Cancer Centre, Glasgow.
  • Glasgow Head & Neck cancer (GlaHNC) research group, CRUK RadNet Glasgow+, United Kingdom.
  • Queen Elizabeth University Hospital, Glasgow.
  • Glasgow Royal Infirmary, Glasgow.
  • CRUK Scotland Institute, University of Glasgow, Glasgow.
  • Patient and public involvement representative, United Kingdom.

Förderung

  • Beatson Cancer Charity

Zitieren

APA

Anderson, S., Douglas, M. C., Valentine, R., Grocutt, L., Inman, G. J., Hay, L., Wright, S., Mair, K., Kelly, C., Seddon, R., Shaw, A., A, M., Gourlay, J., Flach, J., Au, E., Vens, C., Schoenherr, C., Grose, D., Lamb, C., …, & Paterson, C. (2026). Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study – Study protocol. Clinical and Translational Radiation Oncology, 60, 101245. https://doi.org/10.1016/j.ctro.2026.101245

Vancouver

Anderson S, Douglas MC, Valentine R, Grocutt L, Inman GJ, Hay L, et al. Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study – Study protocol. Clinical and Translational Radiation Oncology. 2026;60:101245. doi:10.1016/j.ctro.2026.101245

BibTeX
@article{Anderson2026,
  author = {Anderson, S and Douglas, M C and Valentine, R and Grocutt, L and Inman, G J and Hay, L and Wright, S and Mair, K and Kelly, C and Seddon, R and Shaw, A and A, MacMillan and Gourlay, J and Flach, J and Au, E and Vens, C and Schoenherr, C and Grose, D and Lamb, C and Schipani, S and Vohra, S and Wilson, C and Paterson, C},
  title = {Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study – Study protocol},
  journal = {Clinical and Translational Radiation Oncology},
  year = {2026},
  volume = {60},
  pages = {101245},
  doi = {10.1016/j.ctro.2026.101245}
}
Kostenlos starten →